Article: Nicotinamide Riboside Supplementation Enhances Walking Performance in Peripheral Artery Disease: Clinical Findings

Jun 13, 2024 Cardiovascular Disease Cardiovascular Health Clinical Healthy Aging & Longevity

Nicotinamide Riboside Supplementation Enhances Walking Performance in Peripheral Artery Disease: Clinical Findings

Objectives

To assess the effects of NR supplementation alone and in combination with resveratrol on the six-minute walk distance in individuals with peripheral artery disease (PAD).

Journal

Nature Communications

Key Outcomes

NR supplementation significantly improved treadmill walking time and the six-minute walking distance (by 17.6 meters), a clinically meaningful change.
NR effectively improved walking performance in individuals with PAD, while resveratrol did not enhance the benefits of NR.
NR combined with resveratrol did not significantly improve the six-minute walk distance compared to placebo.

Duration

6 months

Dose

1000 mg*
*Patients were given NR (1000 mg) or NR (1000 mg) + Resveratrol (125 mg).

Study Design

Randomized, double-blind, placebo-controlled, phase II study in 90 peripheral artery disease (PAD) patients

See Published Study

Metabolic Health

A Novel Ketogenic Diet Reduces Seizure Severity and Prevents Fatty Liver in Epileptogenesis: Preclinical Findings

Synopsis Drug-resistant epilepsy remains difficult to manage, and while the ketogenic diet (KD) can help reduce seizures, its high fat content often causes metabolic side effects and poor patient ...

Neurological Health

Nicotinamide Riboside Improves Survival and Motor Function in Parkinson’s Disease: Preclinical Findings

Synopsis Parkinson’s disease (PD) is a neurodegenerative disorder marked by the loss of dopamine-producing neurons, leading to motor dysfunction and other symptoms. This study investigated how nic...